Kenvue Inc. (NYSE:KVUE) Shares Sold by Nordea Investment Management AB

Nordea Investment Management AB cut its holdings in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 8.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,618,899 shares of the company's stock after selling 587,409 shares during the period. Nordea Investment Management AB owned approximately 0.35% of Kenvue worth $141,777,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the business. Huntington National Bank grew its stake in shares of Kenvue by 26.5% in the third quarter. Huntington National Bank now owns 4,161 shares of the company's stock worth $96,000 after acquiring an additional 871 shares during the period. ING Groep NV raised its stake in Kenvue by 23.6% during the 3rd quarter. ING Groep NV now owns 3,576,616 shares of the company's stock valued at $82,727,000 after buying an additional 681,954 shares during the last quarter. Kennon Green & Company LLC raised its stake in shares of Kenvue by 140.7% in the second quarter. Kennon Green & Company LLC now owns 159,106 shares of the company's stock worth $2,893,000 after buying an additional 93,008 shares during the period. Saturna Capital Corp raised its stake in Kenvue by 29.9% during the 3rd quarter. Saturna Capital Corp now owns 1,334,860 shares of the company's stock worth $30,875,000 after acquiring an additional 307,039 shares during the period. Finally, Tyler Stone Wealth Management lifted its holdings in Kenvue by 134.4% during the third quarter. Tyler Stone Wealth Management now owns 49,050 shares of the company's stock valued at $1,135,000 after purchasing an additional 28,125 shares in the last quarter. 97.64% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the stock. Jefferies Financial Group initiated coverage on shares of Kenvue in a research note on Tuesday, September 24th. They set a "buy" rating and a $27.00 target price on the stock. JPMorgan Chase & Co. lifted their price objective on Kenvue from $24.00 to $25.00 and gave the stock an "overweight" rating in a research note on Friday, October 11th. Bank of America lifted their price objective on shares of Kenvue from $24.00 to $27.00 and gave the stock a "buy" rating in a research note on Tuesday, October 22nd. Royal Bank of Canada upgraded Kenvue from a "hold" rating to a "moderate buy" rating in a report on Monday, December 9th. Finally, Barclays raised shares of Kenvue to a "hold" rating in a research report on Thursday, December 12th. One analyst has rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $23.09.

Kenvue Stock Down 0.4 %

Shares of NYSE:KVUE traded down $0.08 during trading hours on Tuesday, hitting $21.03. The company's stock had a trading volume of 8,828,761 shares, compared to its average volume of 8,475,540. The firm's fifty day moving average price is $22.77 and its 200 day moving average price is $21.54. Kenvue Inc. has a 52 week low of $17.67 and a 52 week high of $24.46. The company has a market capitalization of $40.32 billion, a price-to-earnings ratio of 38.24, a P/E/G ratio of 2.02 and a beta of 1.46. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.00 and a quick ratio of 0.69.

Kenvue (NYSE:KVUE - Get Free Report) last issued its quarterly earnings data on Thursday, November 7th. The company reported $0.28 earnings per share for the quarter, topping analysts' consensus estimates of $0.27 by $0.01. Kenvue had a return on equity of 21.43% and a net margin of 6.88%. The firm had revenue of $3.90 billion during the quarter, compared to analysts' expectations of $3.92 billion. During the same period in the prior year, the business posted $0.31 EPS. The firm's quarterly revenue was down .4% on a year-over-year basis. As a group, research analysts expect that Kenvue Inc. will post 1.07 EPS for the current year.

Kenvue Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, November 27th. Stockholders of record on Wednesday, November 13th were issued a dividend of $0.205 per share. The ex-dividend date of this dividend was Wednesday, November 13th. This represents a $0.82 annualized dividend and a dividend yield of 3.90%. Kenvue's dividend payout ratio is presently 149.09%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.